Archive | Quarterly Report

RSS feed for this section

SIAPS Activity and Product Status Report: Year 6, Quarter 4

This report presents highlights of SIAPS’s activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the July through September 2017 period.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 6, Quarter 3

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the April through June 2017 period.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 6, Quarter 2

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the January through March 2017 period.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 6, Quarter 1

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the October through December 2016 period.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 5, Quarter 4

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the July through September 2016 period.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 5, Quarter 3

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the April through June 2016 period.

Read full story · Comments are closed

Quarterly Activity Report for SIAPS/Mali FY15 Funds: January—March 2016

This report is requested by the US Agency for International Development (USAID) Mali Mission on a quarterly basis. Its purpose is to present information on progress in the implementation of activities that the Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program in Mali planned for its program year (PY) 5 work plan.

The report describes achievements and related indicators, challenges, and lessons learned as well as progress in the areas of gender integration, family planning compliance activities, Ebola activities, and the environmental report.

A summary narrative on activities undertaken during the second quarter of PY5 is provided, as is an indicators table presenting the cumulative achievements to date.

During the second quarter of PY5, SIAPS supported the Ministry of Health (MOH) in implementing several activities with the aim of strengthening pharmaceutical governance, building capacity of individuals and institutions in pharmaceutical management, making logistics data available for decision making, and strengthening pharmaceutical services.

The data also suggest areas where efforts should be maintained or increased in terms of support to health facilities and services to patients through continuous coaching and supportive supervision visits.

Read full story · Comments are closed

Systems for Improved Access to Pharmaceuticals and Services: Malaria Quarterly Update – January—March 2016

Working closely with the President’s Malaria Initiative (PMI) in both Washington and PMI- focus countries, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on the PMI’s priorities, SIAPS endeavors to improve pharmaceutical governance, build capacity to manage malaria products while addressing the information needed for managing them, strengthen financing strategies and mechanisms to improve access to malaria medicines, and improve the quality of pharmaceutical services provided to malaria patients.

The SIAPS technical approach emphasizes health systems strengthening with a special focus on improving metrics, monitoring and evaluation (M&E), developing the capacity of local governments and organizations, and increasing country ownership. Through this approach, SIAPS aims to promote the availability and use of malaria products, including artemisinin-based combination therapy (ACT), rapid diagnostic tests (RDT), and medicines for severe malaria. At the country level, SIAPS collaborates with national malaria control programs and Central Medical Stores (CMS) to develop and implement strategies to strengthen pharmaceutical management to prevent and improve case management of malaria. Areas supported by SIAPS include: training; quantification; strengthening supply chain systems, including logistics management information; community and malaria case management; rational use; and medication safety. SIAPS works to strengthen malaria pharmaceutical management at the national level in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, Niger, and South Sudan. In addition, SIAPS provides regional support in Latin America.

This report describes the major activities that SIAPS conducted at the global level and in each of the countries and region mentioned above between January and March 2016.

Read full story · Comments are closed

SIAPS Activity and Product Status Report: Year 5, Quarter 2

This report presents highlights of SIAPS’ activities organized both by intermediate result area, representing multiple countries where we work, as well as by our global, regional, and country portfolios for the January through March 2016 period.

Read full story · Comments are closed

Systems for Improved Access to Pharmaceuticals and Services: Malaria Quarterly Update

According to the World Health Organization (WHO), the number of malaria deaths malaria mortality rates fell by 48% globally, and the number of malaria cases by 18% between 2000 and 2015. During this period, it is estimated that 6.2 million fewer malaria deaths occurred globally, primarily as a result of the scale-up of interventions. However, much remains to be done. Despite impressive gains in malaria intervention coverage, millions of people still do not receive the services they need.

Working closely with the President’s Malaria Initiative (PMI) in both Washington and PMI focus countries, the US Agency for International Development (USAID)-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program aims to ensure the availability of quality pharmaceutical products and effective pharmaceutical services in support of PMI objectives. To this end, and based on the PMI’s priorities, SIAPS endeavors to improve pharmaceutical governance, build capacity to manage malaria products while addressing the information needed for managing them, strengthen financing strategies and mechanisms to improve access to malaria medicines, and improve the quality of pharmaceutical services provided to malaria patients.

The SIAPS technical approach emphasizes health systems strengthening with a special focus on improving metrics, monitoring and evaluation (M&E), developing the capacity of local governments and organizations, and increasing country ownership. Through this approach, SIAPS aims to promote the availability and use of malaria products, including artemisinin-based combination therapy (ACT), rapid diagnostic tests (RDT), and medicines for severe malaria. At the country level, SIAPS collaborates with national malaria control programs and Central Medical Stores (CMS) to develop and implement strategies to strengthen pharmaceutical management to prevent and improve case management of malaria. Areas supported by SIAPS include: training; quantification; strengthening supply chain systems, including logistics management information; community and malaria case management; rational use; and medication safety. SIAPS works to strengthen malaria pharmaceutical management at the national level in Angola, Burundi, the Democratic Republic of the Congo (DRC), Ethiopia, Guinea, Mali, Niger, and South Sudan. In addition, SIAPS provides regional support in Latin America.

This report describes the major activities that SIAPS conducted at the global level and in each of the countries and region mentioned above between October and December 2015.

Read full story · Comments are closed